Author:
Nakano Yumiko,Matsuzono Kosuke,Yamashita Toru,Ohta Yasuyuki,Hishikawa Nozomi,Sato Kota,Deguchi Kentaro,Abe Koji
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience
Reference17 articles.
1. American Psychiatric Association practice guideline for thetreatment of patients with Alzheimer’s disease and other dementias. Second edition;APA;Am J Psychiatry,2007
2. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis;Tan;J Alzheimers Dis,2014
3. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer’s disease;Di;J Alzheimers Dis,2013
4. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis;Hansen;Clin Interv Aging,2008
5. Galantamine: Additional benefits to patients with Alzheimer’s disease;Lilienfeld;Dement Geriatr Cogn Disord,2000
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献